Sort by
Items per page

Send to

Choose Destination

Best matches for "1,3,7,9-tetrabromodibenzo-p-dioxin" and (“androgen” or “androgenic” or “adrenergic” or “antiadrenergic” or “antiandrogen” or “antiandrogenic” or “antiestrogenic” or “antithyroid” or “aromatase” or “catecholamines” or “EDCs” or “endocrine” or “ERalpha” or “estradiol” or “estrogen” or “estrogenic” or “estrogenicity” or “fertility” or “glucocorticoid” or “hormone” or “proestrogenic” or “progesterone” or “progesteronic” or “reproductive” or “semen” or “sperm” or “spermatogenesis” or “steoroids” or “thyroid” or “urogenital” or “xenoestrogen” or “xenoestrogenic” or “xenoestrogens” or “imposex” or “cancer” or “ovary” or “pregnancy” or “testosterone” or “uterus” or “tumor”):

Search results

Items: 1 to 20 of 347117

  • The following terms were not found in PubMed: 9-tetrabromodibenzo-p-dioxin, steoroids.
  • Quoted phrase not found.

[Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide].

Liu JW, Lu X, Yang ZM, Deng LJ, Yang L.

Beijing Da Xue Xue Bao. 2017 Oct 18;49(5):840-846. Chinese.


Impact of Gastric Cancer Surgery in Elderly Patients.

Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, Toyokawa A.

Oncology. 2017 Oct 19. doi: 10.1159/000481404. [Epub ahead of print]


Suicide deaths among patients with end-stage renal disease receiving dialysis: A population-based retrospective cohort study of 64,000 patients in Taiwan.

Chen IM, Lin PH, Wu VC, Wu CS, Shan JC, Chang SS, Liao SC.

J Affect Disord. 2017 Oct 9;227:7-10. doi: 10.1016/j.jad.2017.10.020. [Epub ahead of print]


Trends in Pelvic Inflammatory Disease Emergency Department Visits, United States, 2006-2013.

Kreisel K, Flagg EW, Torrone E.

Am J Obstet Gynecol. 2017 Oct 15. pii: S0002-9378(17)31193-6. doi: 10.1016/j.ajog.2017.10.010. [Epub ahead of print]


Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod and topical 5-fluorouracil in patients with superficial basal cell carcinoma.

Jansen MHE, Mosterd K, Arits AHMM, Roozeboom MH, Sommer A, Essers BAB, van Pelt HPA, Quaedvlieg PJF, Steijlen PM, Nelemans PJ, Kelleners-Smeets NWJ.

J Invest Dermatol. 2017 Oct 15. pii: S0022-202X(17)33045-2. doi: 10.1016/j.jid.2017.09.033. [Epub ahead of print]


Identification of natural products as inhibitors of human organic anion transporters (OAT1 and OAT3) and their protective effect on mercury-induced toxicity.

Wang X, Han L, Li G, Peng W, Gao X, Klaassen CD, Fan G, Zhang Y.

Toxicol Sci. 2017 Oct 13. doi: 10.1093/toxsci/kfx216. [Epub ahead of print]


Hospice Utilization in Patients with Malignant Gliomas.

Forst D, Adams E, Nipp R, Martin A, El-Jawahri A, Aizer A, Jordan JT.

Neuro Oncol. 2017 Oct 16. doi: 10.1093/neuonc/nox196. [Epub ahead of print]


Age-related changes in the mitochondria of human mural granulosa cells.

Liu Y, Han M, Li X, Wang H, Ma M, Zhang S, Guo Y, Wang S, Wang Y, Duan N, Xu B, Yin J, Yao Y.

Hum Reprod. 2017 Oct 17:1-9. doi: 10.1093/humrep/dex309. [Epub ahead of print]


Survey of Reproductive Experiences and Outcomes of Cancer Survivors Who Stored Reproductive Material Before Treatment.

Hammarberg K, Kirkman M, Stern C, McLachlan RI, Clarke G, Agresta F, Gook D, Rombauts L, Vollenhoven B, Fishe JRW.

Hum Reprod. 2017 Oct 17:1-8. doi: 10.1093/humrep/dex314. [Epub ahead of print]


Bevacizumab + chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial - PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa FA, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; PRODIGE 20 investigators.

Ann Oncol. 2017 Sep 28. doi: 10.1093/annonc/mdx529. [Epub ahead of print]


Patient and tumor characteristics and their influence on early therapy persistence with letrozole in postmenopausal patients with early breast cancer.

Nabieva N, Kellner S, Fehm T, Häberle L, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Wuerstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesselt T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauss T, Thomssen C, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Brucker SY, Kümmel S, Beckmann MW, Wallwiener D, Hadji P, Fasching PA.

Ann Oncol. 2017 Oct 10. doi: 10.1093/annonc/mdx630. [Epub ahead of print]


Generation of transgenic marmosets using a tetracyclin-inducible transgene expression system as a neurodegenerative disease model.

Tomioka I, Nogami N, Nakatani T, Owari K, Fujita N, Motohashi H, Takayama O, Takae K, Nagai Y, Seki K.

Biol Reprod. 2017 Oct 13. doi: 10.1093/biolre/iox129. [Epub ahead of print]


Attenuation of high-frequency (30-200 Hz) thalamocortical EEG rhythms as correlate of anaesthetic action: evidence from dexmedetomidine.

Plourde G, Arseneau F.

Br J Anaesth. 2017 Oct 16. doi: 10.1093/bja/aex329. [Epub ahead of print]


Inflammatory gastrointestinal diseases associated with PD-1 Blockade Antibodies.

Collins M, Michot J, Danlos F, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin A, Soria J, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Oct 3. doi: 10.1093/annonc/mdx403. [Epub ahead of print]


Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.

Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HA Jr, Desir J, Delbaere A, t'Kint de Roodenbeke MD, de Azambuja E, Ignatiadis M, Demeestere I.

Ann Oncol. 2017 Oct 10. doi: 10.1093/annonc/mdx639. [Epub ahead of print]


Veliparib With Temozolomide or Carboplatin/Paclitaxel Versus Placebo With Carboplatin/Paclitaxel in Patients With BRCA1/2 Locally Recurrent/Metastatic Breast Cancer: Randomized Phase II Study.

Han HS, Diéras V, Robson M, Palácová M, Marcom PK, Jager A, Bondarenko I, Citrin D, Campone M, Telli ML, Domchek SM, Friedlander M, Kaufman B, Garber JE, Shparyk Y, Chmielowska E, Jakobsen EH, Kaklamani V, Gradishar W, Ratajczak CK, Nickner C, Qin Q, Qian J, Shepherd SP, Isakoff SJ, Puhalla S.

Ann Oncol. 2017 Sep 29. doi: 10.1093/annonc/mdx505. [Epub ahead of print]


Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.

Jain S, Lyons CA, Walker SM, McQuaid S, Hynes S, Mitchell D, Pang B, Logan GE, McCavigan AM, O'Rourke D, McArt D, McDade S, Mills I, Prise KM, Knight LA, Steele CJ, Medlow PW, Berge V, Katz B, Loblaw DA, Harkin DP, James J, O'Sullivan JM, Kennedy RD, Waugh DJ.

Ann Oncol. 2017 Oct 10. doi: 10.1093/annonc/mdx637. [Epub ahead of print]


Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long GV, Menzies AM, Eroglu Z, Johnson DB, Shoushtari AN.

Ann Oncol. 2017 Oct 11. doi: 10.1093/annonc/mdx642. [Epub ahead of print]


SELECT-2: a Phase II, double-blind, randomised, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment for patients with advanced or metastatic non-small cell lung cancer.

Soria JC, Fülöp A, Maciel C, Fischer JR, Girotto G, Lago S, Smit E, Ostoros G, Eberhardt WEE, Lishkovska P, Lovick S, Mariani G, McKeown A, Kilgour E, Smith P, Bowen K, Kohlmann A, Carlile DJ, Jänne PA.

Ann Oncol. 2017 Oct 3. doi: 10.1093/annonc/mdx628. [Epub ahead of print]


Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer.

Fribbens C, Garcia Murillas I, Beaney M, Hrebien S, O'Leary B, Kilburn L, Howarth K, Epstein M, Green E, Rosenfeld N, Ring A, Johnston S, Turner N.

Ann Oncol. 2017 Oct 4. doi: 10.1093/annonc/mdx483. [Epub ahead of print]


Supplemental Content

Loading ...
Support Center